Probiotic: The trial period of this study is 3 months, and each patient will undergo 4 visits (in month 0, month 1, month 2, and month 3).
Maltodextrin: The trial period of this study is 3 months, and each patient will undergo 4 visits (in month 0, month 1, month 2, and month 3).
Study summary
To evaluate the regulatory effect of Lactobacillus plantans Lp90 formula on visceral fat metabolism and sex hormone balance in obese women.
Eligibility
Sex
FEMALE
Min age
18 Years
Max age
40 Years
Healthy volunteers
Accepted
Inclusion Criteria:
1. Age: 18 to 40 years old, female, BMI ≥ 25 kg/m2.
2. Be willing to receive follow-up during the intervention period.
3. Be willing to provide two blood, urine and fecal samples during the intervention period.
4. Be willing to take the compound probiotics by oneself every day during the intervention period.
5. Have good hearing and be able to hear and understand all instructions during the intervention period.
\-
Exclusion Criteria:
1. Suffering from digestive system diseases, mainly gastrointestinal diseases (celiac disease, ulcerative colitis, Crohn's disease).
2. Suffering from severe neurological disorders (epilepsy, stroke, severe head trauma, meningitis within the past 10 years, brain surgery, brain tumor, long-term coma - excluding general anesthesia).
3. Have received/are currently receiving treatment for the following mental illnesses: alcohol/drug/substance abuse dependence, schizophrenia, psychosis, bipolar disorder.
4. Take medication for depression or low mood.
5. Suffering from internal organ failure (such as heart, liver or kidney failure, etc.).
6. Have received radiotherapy or chemotherapy in the past.
7. Have received general anesthesia surgery/procedures within the past three years, or plan to receive general anesthesia procedures/surgeries within the next three months during this trial.
8. Have suffered from hepatitis (hepatitis B, hepatitis C), HIV or syphilis in the past.
\-
Primary outcome measure(s)
The changes of estradiol before and after the intervention — 0, 1, 2, 3 months The serum estrogen content of the subjects before and after the intervention was detected by enzyme-linked immunosorbent assay.
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.